These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Coadministration of phenelzine and methylphenidate for treatment-resistant depression. Shelton Clauson A; Elliott ES; Watson BD; Treacy J Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373 [No Abstract] [Full Text] [Related]
5. Elderly depressed females as a possible subgroup of patients responsive to methylphenidate. Askinazi C; Weintraub RJ; Karamouz N J Clin Psychiatry; 1986 Sep; 47(9):467-9. PubMed ID: 3745129 [TBL] [Abstract][Full Text] [Related]
6. Should psychostimulants be used to treat delirious patients with depressed mood? Levenson JA J Clin Psychiatry; 1992 Feb; 53(2):69. PubMed ID: 1541609 [No Abstract] [Full Text] [Related]
7. [Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature]. Buhagiar K; Cassar J Turk Psikiyatri Derg; 2007; 18(2):179-83. PubMed ID: 17566884 [TBL] [Abstract][Full Text] [Related]
8. The use of methylphenidate in depressed patients after cardiac surgery. Kaufmann MW; Cassem N; Murray G; MacDonald D J Clin Psychiatry; 1984 Feb; 45(2):82-4. PubMed ID: 6693366 [TBL] [Abstract][Full Text] [Related]
9. d-Amphetamine versus methylphenidate effects in depressed inpatients. Little KY J Clin Psychiatry; 1993 Sep; 54(9):349-55. PubMed ID: 8407854 [TBL] [Abstract][Full Text] [Related]
12. Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants. Fernandez F; Adams F; Holmes VF; Levy JK; Neidhart M Psychosomatics; 1987 Sep; 28(9):455-61. PubMed ID: 3432548 [No Abstract] [Full Text] [Related]
13. What are the pharmacologic considerations when treating depression in patients with HIV infection? Swenson JR J Psychiatry Neurosci; 1998 May; 23(3):200. PubMed ID: 11499431 [No Abstract] [Full Text] [Related]
14. A rapid response with psychostimulants in the treatment of depressed persons with medical illnesses. Roy M; Bernier J Can J Psychiatry; 1999 Apr; 44(3):283-4. PubMed ID: 10225132 [No Abstract] [Full Text] [Related]
15. Methylphenidate in stroke patients with depression. Johnson ML; Roberts MD; Ross AR; Witten CM Am J Phys Med Rehabil; 1992 Aug; 71(4):239-41. PubMed ID: 1642825 [TBL] [Abstract][Full Text] [Related]
16. Diurnal variation in methylphenidate stimulant response in major depression. Swift RM J Clin Psychopharmacol; 1989 Dec; 9(6):452. PubMed ID: 2592594 [No Abstract] [Full Text] [Related]
17. Low-dose methylphenidate in the very old. Gurian B; Rosowsky E J Geriatr Psychiatry Neurol; 1990; 3(3):152-4. PubMed ID: 2282131 [TBL] [Abstract][Full Text] [Related]
18. The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate. Gwirtsman HE; Szuba MP; Toren L; Feist M Psychopharmacol Bull; 1994; 30(2):157-64. PubMed ID: 7831449 [TBL] [Abstract][Full Text] [Related]
19. Methylphenidate for medical in-patients. Fisch RZ Int J Psychiatry Med; 1985-1986; 15(1):75-9. PubMed ID: 4055249 [TBL] [Abstract][Full Text] [Related]
20. Methylphenidate may treat apathy independent of depression. Padala PR; Petty F; Bhatia SC Ann Pharmacother; 2005 Nov; 39(11):1947-9. PubMed ID: 16204387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]